Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 14 Jun 2024 | 9 Jun 2024 |
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2024 inter alia to consider and approve To Discuss and reconsider the Investment Planning and Fund-raising Proposal etc. | ||
Board Meeting | 5 Jun 2024 | 1 Jun 2024 |
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve To Discuss and Consider the Investment Planning and Fund-raising Proposal mode of funding To authorized Mr. Suraj Zanwar- Managing Director of company to prepare details plan of Investment proposal and working capital requirement of the company (As Per BSE Announcement Dated on 09.06.2024) | ||
Board Meeting | 30 May 2024 | 20 May 2024 |
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve To consider and approve Audited financial results for Year ended on 31st march 2024 Revised financials for financial year ending on 31st march 2024 due to mission of attachment consolidated results (As Per BSE Announcement Dated on 31.05.2024) | ||
Board Meeting | 17 Jan 2024 | 18 Jan 2024 |
Intimation of Appointment of Mr. Prateek Shriprakash Kulkarni as an Independent Director of company w.e.f. 17th January, 2024 | ||
Board Meeting | 30 Dec 2023 | 30 Dec 2023 |
Revised Outcome of Board meeting for migration of Companys present listing of equity shares from SME Platform of BSE Limited to Main Board of NSE Platform. Filing revised Outcome as in earlier outcome we by mistake mentioned as NSE Emerge instead of NSE Main Board. Migration of Companys present listing of Equity Shares from SME Platform of BSE Limited to the Main Board of NSE Emerge Platform. | ||
Board Meeting | 14 Nov 2023 | 6 Nov 2023 |
Half Yearly Results Outcome of Meeting of board of Director dated 14th November, 2023 Declaration of financial results for the half year ended on 30th September, 2023 (As Per BSE Announcement Dated on 14/11/2023) | ||
Board Meeting | 12 Oct 2023 | 12 Oct 2023 |
Intimation of appointment of Additional Director (Executive category) w.e.f 11th October, 2023. |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.